- Home
- HOWL vs MKTW Comparison
HOWL vs MKTW Comparison
Compare HOWL & MKTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- MKTW
- Stock Information
- Founded
- HOWL 2017
- MKTW 1999
- Country
- HOWL United States
- MKTW United States
- Employees
- HOWL N/A
- MKTW N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- MKTW Computer Software: Prepackaged Software
- Sector
- HOWL Health Care
- MKTW Technology
- Exchange
- HOWL Nasdaq
- MKTW Nasdaq
- Market Cap
- HOWL 50.3M
- MKTW 45.4M
- IPO Year
- HOWL 2021
- MKTW N/A
- Fundamental
- Price
- HOWL $1.20
- MKTW $16.63
- Analyst Decision
- HOWL Strong Buy
- MKTW
- Analyst Count
- HOWL 3
- MKTW 0
- Target Price
- HOWL $8.33
- MKTW N/A
- AVG Volume (30 Days)
- HOWL 643.1K
- MKTW 27.5K
- Earning Date
- HOWL 05-08-2025
- MKTW 05-08-2025
- Dividend Yield
- HOWL N/A
- MKTW 4.39%
- EPS Growth
- HOWL N/A
- MKTW 207.28
- EPS
- HOWL N/A
- MKTW 3.12
- Revenue
- HOWL $1,143,000.00
- MKTW $383,217,000.00
- Revenue This Year
- HOWL N/A
- MKTW N/A
- Revenue Next Year
- HOWL $900.00
- MKTW $0.42
- P/E Ratio
- HOWL N/A
- MKTW $5.38
- Revenue Growth
- HOWL N/A
- MKTW N/A
- 52 Week Low
- HOWL $0.60
- MKTW $9.08
- 52 Week High
- HOWL $5.73
- MKTW $29.00
- Technical
- Relative Strength Index (RSI)
- HOWL 61.01
- MKTW 58.23
- Support Level
- HOWL $1.18
- MKTW $15.42
- Resistance Level
- HOWL $1.31
- MKTW $18.78
- Average True Range (ATR)
- HOWL 0.11
- MKTW 0.85
- MACD
- HOWL 0.02
- MKTW -0.10
- Stochastic Oscillator
- HOWL 68.83
- MKTW 39.61
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.